AEVI GENOMIC Stock Price (NASDAQ:GNMX)

Add to My Stocks
$1.35 $0.03 (2.17%) GNMX stock closing price Sep 19, 2018 (Closing)
Prev Close* : $1.38
Market Cap:
$77.14M
Day Low: $1.3
52 Week Low: $0.83
Open: $1.38
Volume: -
Day High: $1.4
52 Week High: $2.65
Dividend:
0.00

Latest Stock Market News

Latest Articles

AEVI GENOMIC News - From Partners

GNMX Stockcharts

View GNMX PE ratio, PS ratio stocks charts and compare with peers.
GNMX Chart
Note: Compare AEVI GENOMIC stock price history with the index and industry peers.

AEVI GENOMIC Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

AEVI GENOMIC Returns

ROE
(return on equity)

AEVI GENOMIC Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

GNMX Industry Peers

Company Price Change (%)
Sol Gel Tech (SLGL)7.130.08 (1.13%)
Zynerba Pharma (ZYNE)7.860.57 (7.82%)
Aquinox Pharma (AQXP)2.770.07 (2.46%)
Evoke Pharma (EVOK)3.180.14 (4.22%)
Odyssey Marine Exploration (OMEX)7.620.25 (3.18%)
Fibrogen (FGEN)56.31.05 (1.83%)
Akebia Therapeutics (AKBA)7.740.04 (0.51%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Progenics Pharma (PGNX)6.420.42 (7%)
Supernus Pharma (SUPN)47.91 (2.13%)
Mylan (MYL)38.240.43 (1.14%)
BAUSCH HEALTH (BHC)24.070.26 (1.09%)
Allergan (AGN)188.031.96 (1.05%)
Dr. Reddy's Laboratories (RDY)36.20.35 (0.98%)
Adamas Pharma (ADMS)18.820.15 (0.8%)
Top gainers from Medical-Generic Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
Mallinckrodt (MNK)29.680.11 (0.37%)
Corium (CORI)8.920.01 (0.11%)
Top losers from Medical-Generic Drugs industry
* As of Sep 19, 2018

AEVI GENOMIC Stock News - Partner Headlines

AEVI GENOMIC Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-34.71M-41.9M-37.99M-18.43M-17.12M
Total Operating Expense34.69M41.87M36.56M18.93M17.81M
View AEVI GENOMIC income statement
balance sheet20172016201520142013
Total Assets34.76M40.56M54.25M34.28M23.08M
Total Liabilities4.14M5.58M3.9M4.61M4.66M
Shareholders Equity30.62M34.97M50.35M29.66M18.42M
View AEVI GENOMIC balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.04M2.09M-0.1M--
Net Cash from (used by) Operating Activities-33.24M-32.74M-24.34M-12.19M-12.73M
Increase (Decrease) in Prop Plant And Equipment--0.22M-0.18M-0.36M-0.18M
View AEVI GENOMIC cash flow statement

AEVI GENOMIC Stock Message Board

As of last trading day, AEVI GENOMIC stock price was $1.35. Looking at AEVI GENOMIC market capitalization, which currently stands at $77.14M, we can say that GNMX stock is a Micro Cap stock. AEVI GENOMIC valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of AEVI GENOMIC stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 87,737 on the last trading day, as is evident from AEVI GENOMIC stock chart, and GNMX stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. AEVI GENOMIC stock dividend was 0.00 during the last quarter. AEVI GENOMIC stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.